Investing Ideas
/
US Artificial Intelligence (AI) Powered Medical Diagnosis Stocks

US Artificial Intelligence (AI) Powered Medical Diagnosis Stocks

Results

2 new

AI is revolutionizing medical diagnosis by leveraging advanced machine learning and data analytics to achieve unprecedented accuracy and speed. Trained on massive datasets of medical images, lab results, and patient histories, AI systems can detect conditions like cancer, heart disease, or neurological disorders earlier and more reliably than traditional methods, often spotting subtle patterns that elude human clinicians. For example, AI-powered tools are already surpassing radiologists in identifying tumors on X-rays or MRIs, reducing misdiagnoses and enabling earlier interventions. Beyond imaging, AI integrates real-time data from wearables—such as heart rate or glucose levels—to flag anomalies instantly, shifting diagnosis from reactive to proactive. While challenges like data quality and regulatory approval persist, AI’s diagnostic prowess promises to make healthcare more precise and timely, potentially saving countless lives through swift, accurate detection.

23 companies

Medtronic

Market Cap: US$106.3b

Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.

MDT

US$83.15

-7.5%

0.3%

Tempus AI

Market Cap: US$7.4b

Operates as a healthcare technology company.

TEM

US$42.70

-11.5%

n/a

Lantheus Holdings

Market Cap: US$6.2b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

LNTH

US$95.45

-2.2%

59.8%

Guardant Health

Market Cap: US$5.0b

A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.

US$41.78

-1.9%

123.9%

RadNet

Market Cap: US$3.6b

Provides outpatient diagnostic imaging services in the United States and internationally.

RDNT

US$49.29

-0.9%

0.9%

Cosmo Pharmaceuticals

Market Cap: US$755.9m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

New

CMOP.F

US$62.80

-18.1%

Cosmo Pharmaceuticals

Market Cap: CHF 755.9m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

New

COPNZ

CHF 47.50

-15.0%

-32.7%

Veradigm

Market Cap: US$678.3m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

MDRX

US$3.90

-10.6%

-52.1%

CeriBell

Market Cap: US$661.4m

Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

CBLL

US$18.19

-5.3%

n/a

Guerbet

Market Cap: €327.8m

Engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.

GBTP

€30.03

n/a

Nano-X Imaging

Market Cap: US$280.6m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

NNOX

US$4.41

-11.7%

-59.3%

Light AI

Market Cap: US$58.5m

A healthcare company, focuses on developing artificial intelligence health diagnostic solutions.

OHCF.F

US$0.35

-12.5%

n/a

Renalytix

Market Cap: US$27.3m

Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.

RENX.F

US$0.091

n/a

Renalytix

Market Cap: US$27.3m

Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.

RNLX.Y

US$0.20

-8.6%

-74.9%

Spectral AI

Market Cap: US$27.3m

An artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.

MDAI

US$1.18

2.6%

-47.3%

Acarix

Market Cap: US$229.2m

A medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out.

ACIX.F

US$0.024

-20.7%

n/a

OneMedNet

Market Cap: US$13.6m

Provides clinical imaging solutions.

ONMD

US$0.51

-6.4%

-34.5%

America Great Health

Market Cap: US$10.6m

Operates as a biotechnology company in the United States.

AAGH

US$0.0005

-75.0%

TrivarX

Market Cap: US$7.9m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

MDBI.F

US$0.0021

n/a

IQ-AI

Market Cap: US$2.7m

Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States.

IQAI.F

US$0.02

n/a

HeartSciences

Market Cap: US$2.9m

A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.

HSCS

US$2.79

-1.2%

-74.3%

Aspira Women's Health

Market Cap: US$2.8m

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.

AWH

US$0.092

-2.2%

-96.7%

EvokAI Creative Labs

Market Cap: US$874.6k

A MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector.

OKAI.F

US$0.17

n/a